Skip to main content
. 2024 Jan 30;14(3):295. doi: 10.3390/diagnostics14030295
SSc Systemic sclerosis
ILD Interstitial lung disease
HRCT High-resolution computed tomography
PFTs Pulmonary function tests
DLCO Diffusion of the lung for carbon oxide
FVC Forced vital capacity
EUSTAR European Scleroderma Trial and Research
dcSSc Diffuse cutaneous subset of SSc
lcSSc Limited cutaneous subset of SSc
ACA Anticentromere antibodies
Topo-I Anti-topoisomerase I
RNA-Pol III Anti-RNA polymerase III antibodies